Marlborough-based Hologic, a medical technology firm specializing in women’s health, has entered into a partnership with international pharmaceutical firm Bayer to provide enhanced imaging mammogram ...

Hologic has put forward more data bolstering the use of its artificial intelligence programs for detecting breast cancer through mammography. The study, conducted at Massachusetts General Hospital and ...

HOLX's Breast Health unit is back in focus as a proposed Blackstone-TPG deal adds a $76 cash offer and CVR to 2026-27 revenue goals.

MARLBOROUGH, Mass., November 25, 2025--(BUSINESS WIRE)--New data on Hologic’s (Nasdaq: HOLX) breast cancer detection technologies will be presented at the Scientific Assembly and Annual Meeting of the ...

Hologic, Inc. (Nasdaq: HOLX), a leading medical technology company dedicated to improving women’s health, today announced new data that highlights how the company’s advanced AI-powered mammography ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic Inc. (Nasdaq: HOLX) and Bayer today announced an international partnership to deliver contrast-enhanced mammography (CEM) solutions to improve the ...

Bayer and Hologic have teamed up with the goal of offering clearer breast cancer scans as a package deal—combining the former’s imaging contrast agents with the latter’s mammography hardware. The two ...

In a retrospective study conducted at Massachusetts General Hospital, researchers analyzed 5,000 digital breast tomosynthesis (3D mammography) screening exams performed between 2016 and 2019 using ...

The Genius ® 3D Mammography ® exam (also known as the Genius ® exam) is only available on a Hologic ® 3D Mammography ® system. It consists of a 2D and 3D ® image set, where the 2D image can be either ...

Research suggests AI may help identify more aggressive breast cancers and perform comparably to experts in breast cancer screening MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Data from two groundbreaking ...